Per Stirling Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$790K Buy
1,669
+1,045
+167% +$526K 0.09% 150
2025
Q4
$291K Sell
624
-1
-0.2% -$464 0.03% 245
2025
Q3
$266K Sell
625
-1,899
-75% -$736K 0.03% 240
2025
Q2
$967K Hold
2,524
0.13% 116
2025
Q1
$872K Hold
2,524
0.13% 123
2024
Q4
$758K Hold
2,524
0.11% 128
2024
Q3
$1.03M Hold
2,524
0.14% 117
2024
Q2
$811K Buy
2,524
+85
+3% +$27.6K 0.13% 113
2024
Q1
$813K Buy
2,439
+1,577
+183% +$482K 0.14% 99
2023
Q4
$233K Sell
862
-1,672
-66% -$413K 0.04% 190
2023
Q3
$623K Hold
2,534
0.13% 101
2023
Q2
$769K Sell
2,534
-969
-28% -$269K 0.16% 84
2023
Q1
$924K Sell
3,503
-2,467
-41% -$627K 0.2% 72
2022
Q4
$1.43M Buy
+5,970
New +$1.34M 0.26% 59

Other funds holding HCA

Per Stirling Capital Management's HCA Position: Q1 2026 in Review

Per Stirling Capital Management increased its HCA Healthcare (HCA) stake by 167% in Q1 2026, buying an estimated $526K and bringing the position to 1,669 shares worth $790K. The position accounts for 0.09% of the portfolio, ranked #150.

Per Stirling Capital Management first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.43M in Q4 2022. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Per Stirling Capital Management held 1,669 shares of HCA Healthcare worth $790K as of Q1 2026.
  • Per Stirling Capital Management bought 1,045 HCA Healthcare shares in Q1 2026, an estimated $526K.
  • HCA Healthcare made up 0.09% of Per Stirling Capital Management's portfolio in Q1 2026, its #150 holding.
  • Per Stirling Capital Management first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • Per Stirling Capital Management's HCA Healthcare position peaked at $1.43M in Q4 2022.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.